Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care.

Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, Januzzi J, Rosenberg J, Senior R, Richards M.

Eur Heart J. 2010 Aug;31(15):1881-9. doi: 10.1093/eurheartj/ehq163. Epub 2010 Jun 2. Review.

PMID:
20519241
2.

Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.

Goode KM, Clark AL, Cleland JG.

Int J Cardiol. 2008 Nov 28;130(3):426-37. doi: 10.1016/j.ijcard.2007.08.131. Epub 2008 Feb 21.

PMID:
18178273
3.

Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.

Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.

Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.

PMID:
16516185
4.

NT-proBNP and the diagnosis of left ventricular systolic dysfunction within two acute NHS trust catchment areas: the initial Teesside experience.

Turley AJ, Roberts AP, Davies A, Rowell N, Drury J, Smith RH, Shyam-Sundar A, Stewart MJ.

Postgrad Med J. 2007 Mar;83(977):206-8.

6.
7.

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.

Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, Dubourg O, Boileau C, Jondeau G, Puy H.

Biomed Pharmacother. 2005 Jan-Feb;59(1-2):20-4. Epub 2005 Jan 20.

PMID:
15740931
9.

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.

Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.

J Am Coll Cardiol. 2007 Mar 20;49(11):1193-202. Epub 2007 Mar 6.

10.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

11.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

12.

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.

Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, Lindemans J, van den Meiracker AH.

Am Heart J. 2008 Jul;156(1):71-7. doi: 10.1016/j.ahj.2008.02.021. Epub 2008 May 27.

PMID:
18585499
13.

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.

J Am Coll Cardiol. 2009 May 12;53(19):1783-90. doi: 10.1016/j.jacc.2009.01.057.

14.

N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.

Khan SQ, Narayan H, Ng KH, Dhillon OS, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.

Clin Sci (Lond). 2009 Jun 2;117(1):31-9. doi: 10.1042/CS20080419.

PMID:
19170658
15.

Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations.

Groenning BA, Nilsson JC, Sondergaard L, Pedersen F, Trawinski J, Baumann M, Larsson HB, Hildebrandt PR.

Am Heart J. 2002 May;143(5):923-9.

PMID:
12040359
16.
17.

[Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].

El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, Jondeau G.

Arch Mal Coeur Vaiss. 2006 Mar;99(3):201-7. French.

PMID:
16618022
18.

N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.

Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS.

Int J Cardiol. 2008 Jun 6;126(3):322-32. Epub 2007 Jun 4.

PMID:
17544525
19.

Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.

Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.

J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):238-44. doi: 10.2459/JCM.0b013e3283212ee0.

PMID:
19262210
20.

Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.

Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.

J Card Fail. 2000 Jun;6(2):130-9.

PMID:
10908087

Supplemental Content

Support Center